Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Medtronic
Fish and Richardson
Queensland Health
Julphar
US Department of Justice

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for CC-122

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for CC-122

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
CC-122 ➤ Sign Up Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers Celgene Corporation (Summit, NJ) The United States of America, as Represented by the Secretary, Department of Health and Human Services (Washington, DC) ➤ Sign Up
CC-122 ➤ Sign Up Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies Celgene Corporation (Summit, NJ) ➤ Sign Up
CC-122 ➤ Sign Up Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione Celgene Corporation (Summit, NJ) ➤ Sign Up
CC-122 ➤ Sign Up Methods for the treatment of diseases ameliorated by PDE4 inhibition using dosage titration of apremilast Celgene Corporation (Summit, NJ) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for CC-122

Drugname Country Document Number Estimated Expiration Related US Patent
CC-122 European Patent Office 3313818 2035-06-26 ➤ Sign Up
CC-122 Japan 2018527302 2035-06-26 ➤ Sign Up
CC-122 World Intellectual Property Organization (WIPO) 2016210262 2035-06-26 ➤ Sign Up
CC-122 Australia 2015305449 2034-08-22 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Farmers Insurance
US Department of Justice
Chubb
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.